Testing effectiveness (Phase 2)Study completedNCT03428217
What this trial is testing
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Calithera Biosciences, Inc 444